Effect of acetylsalicylic acid, other nonsteroidal anti-inflammatory agents, and dipyridamole on human blood platelets.
D000227:Adenine Nucleotides / Q000494:pharmacology; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology*; D001792:Blood Platelets / Q000187:drug effects*; D002247:Carbon Isotopes; D002498:Centrifugation; D003238:Connective Tissue / Q000378:metabolism; D004176:Dipyridamole / Q000494:pharmacology*; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology; D005439:Flufenamic Acid / Q000494:pharmacology; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D008528:Mefenamic Acid / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D012701:Serotonin; D012980:Sodium Salicylate / Q000494:pharmacology; D013442:Sulfinpyrazone / Q000494:pharmacology
D000227:Adenine Nucleotides; D000893:Anti-Inflammatory Agents; D002247:Carbon Isotopes; D012701:Serotonin; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D004176:Dipyridamole; D010653:Phenylbutazone; D001241:Aspirin; D013442:Sulfinpyrazone; D012980:Sodium Salicylate; D007213:Indomethacin; D004837:Epinephrine